Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study

BackgroundLong-acting injectable cabotegravir (CAB-LA) for preexposure prophylaxis (PrEP) has proven efficacious in randomized controlled trials. Further research is critical to evaluate its effectiveness in real-world settings and identify effective implementation approaches...

Full description

Bibliographic Details
Main Authors:	Beatriz Grinsztejn, Thiago Silva Torres, Brenda Hoagland, Emilia Moreira Jalil, Ronaldo Ismerio Moreira, Gabrielle O'Malley, Starley B Shade, Marcos R Benedetti, Julio Moreira, Keila Simpson, Maria Cristina Pimenta, Valdiléa Gonçalves Veloso
Format:	Article
Language:	English
Published:	JMIR Publications 2023-04-01
Series:	JMIR Public Health and Surveillance
Online Access:	https://publichealth.jmir.org/2023/1/e44961

Similar Items

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study
by: M Cristina Pimenta, et al.
Published: (2024-10-01)

Preexposure Prophylaxis and Patient Centeredness
by: Jonathan M. Snowden PhD, et al.
Published: (2016-09-01)

The use of preexposure treatments for HIV prophylaxis
by: Majid A, et al.
Published: (2012-02-01)

AIDS vaccines and preexposure prophylaxis: is synergy possible?
by: Excler, J, et al.
Published: (2011)

A Peer-Led Digital Intervention to Reduce HIV Prevention and Care Disparities Among Young Brazilian Transgender Women (The BeT Study): Protocol for an Intervention Study
by: Emilia Moreira Jalil, et al.
Published: (2023-02-01)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
by: David C. Knox, et al.
Published: (2022-01-01)

HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
by: Ank E. Nijhawan, et al.
Published: (2024-04-01)

HIV preexposure prophylaxis and postexposure prophylaxis in women: a comprehensive guide for healthcare providers
by: Niam Vora, et al.
Published: (2024-12-01)

High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil
by: Brenda Hoagland, et al.
Published: (2021-01-01)

Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.
by: Julia L Marcus, et al.
Published: (2014-01-01)

Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in BrazilResearch in context
by: Claudia Cristina de Aguiar Pereira, et al.
Published: (2023-03-01)

HIV Care Continuum and Preexposure Prophylaxis Program in Federal Bureau of Prisons, United States
by: Xiao Hong Huang, et al.
Published: (2024-04-01)

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men
by: Martin Hoenigl, et al.
Published: (2018-12-01)

Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil
by: Amanda Echeverría-Guevara, et al.
Published: (2023-01-01)

Evaluation of Mpox Knowledge, Stigma, and Willingness to Vaccinate for Mpox: Cross-Sectional Web-Based Survey Among Sexual and Gender Minorities
by: Thiago Silva Torres, et al.
Published: (2023-07-01)

Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
by: Haire BG
Published: (2015-10-01)

Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
by: Luana M S Marins, et al.
Published: (2019-01-01)

Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study
by: Kelika A. Konda, et al.
Published: (2022-10-01)

Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil
by: Brenda Hoagland, et al.
Published: (2020-07-01)

Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate
by: Angela Cristina Vasconcelos de Andrade, et al.

Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis
by: Jessica M. Fogel, et al.
Published: (2024-08-01)

INFECÇÕES SEXUALMENTE TRANSMISSÍVEIS (IST) ENTRE HOMENS QUE FAZEM SEXO COM HOMENS (HSH), TRAVESTIS E MULHERES TRANS (TMT) EM USO DE PROFILAXIA PRÉ-EXPOSIÇÃO PARA HIV (PREP) NO BRASIL
by: Mayara Secco Torres da Silva, et al.
Published: (2023-10-01)

Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque model
by: Elena Bekerman, et al.
Published: (2023-08-01)

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models
by: Fei Huang, et al.
Published: (2021-08-01)

Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications
by: Thomas B. Silverman MPH, et al.
Published: (2018-09-01)

No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis.
by: Julia L Marcus, et al.
Published: (2013-01-01)

Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study
by: Kevin James Blair, et al.
Published: (2023-10-01)

Awareness and Uptake of HIV Preexposure Prophylaxis and Postexposure Prophylaxis Among College Students With Sexual Experiences: Institutional-Based Cross-Sectional Study
by: Junfang Xu, et al.
Published: (2024-11-01)

Multitasking Pharmacophores Support Cabotegravir-Based Long-Acting HIV Pre-Exposure Prophylaxis (PrEP)
by: Zheng Wan, et al.
Published: (2024-01-01)

ALTA VULNERABILIDADE E PREVALÊNCIA DE HIV E OUTRAS ISTS ENTRE JOVENS HSH NO RIO DE JANEIRO: O PROJETO CONECTAD@S
by: Cristina Moreira Jalil, et al.
Published: (2023-10-01)

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection
by: Gatanaga, H, et al.
Published: (2017)

132 A Qualitative Exploration of Preexposure Prophylaxis Among Black Women Attending Historically Black Colleges and Universities
by: Marissa Robinson, et al.
Published: (2022-04-01)

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.
by: Andreas B Eisingerich, et al.
Published: (2012-01-01)

Probenecid‐Boosted Tenofovir: A Physiologically‐Based Pharmacokinetic Model‐Informed Strategy for On‐Demand HIV Preexposure Prophylaxis
by: Stephanie N. Liu, et al.
Published: (2020-01-01)

Dog bite, immunoglobulin, and preexposure vaccination
by: Nora Pokee, et al.
Published: (2015-01-01)

Health care providers' decision-making and early adoption of tenofovir alafenamide for HIV preexposure prophylaxis: An inductive qualitative study.
by: Elisabeth Merchant, et al.
Published: (2024-01-01)

Brief communication: attitudes and preferences of long-acting injectable HIV preexposure prophylaxis among Thai adolescents and young adults
by: Alisa Wongsethanatada, et al.
Published: (2025-03-01)

HPV vaccination and HIV preexposure prophylaxis (PrEP): Missed opportunities for anal cancer prevention among at risk populations
by: Christopher W. Wheldon
Published: (2022-11-01)

Technology-Based Interventions to Promote the HIV Preexposure Prophylaxis (PrEP) Care Continuum: Protocol for a Systematic Review
by: Chenglin Hong, et al.
Published: (2022-03-01)

A Technology-Based Intervention Among Young Men Who Have Sex With Men and Nonbinary People (The Conectad@s Project): Protocol for A Vanguard Mixed Methods Study
by: Thiago Silva Torres, et al.
Published: (2022-01-01)